Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome

被引:17
|
作者
Yi, Kyu-Ho [1 ,2 ]
Lee, Ji-Hyun [2 ]
Kim, Hee-Jin [2 ,3 ]
机构
[1] Wonju City Publ Hlth Ctr, COVID 19 Div, Wonju 26417, South Korea
[2] Yonsei Univ, Coll Dent, Human Identificat Res Inst, Div Anat & Dev Biol,Dept Oral Biol,BK21 FOUR Proj, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Engn, Dept Mat Sci & Engn, Seoul 03722, South Korea
关键词
myofascial pain syndrome; Sihler's method; serratus anterior; trigger point injection; TOXIN TYPE-A; CHRONIC DAILY HEADACHE; TRIGGER POINTS; LIDOCAINE INJECTION; NERVE DISTRIBUTION; DOUBLE-BLIND; NECK PAIN; MIGRAINE; SPASTICITY; TRAPEZIUS;
D O I
10.3390/toxins14040271
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the intramuscular neural distribution using the whole-mount staining method. A modified Sihler method was applied to the serratus anterior muscles (15 specimens). The intramuscular arborization areas were identified in terms of the anterior (100%), middle (50%), and posterior axillary line (0%), and from the first to the ninth ribs. The intramuscular neural distribution for the serratus anterior muscle had the largest arborization patterns in the fifth to the ninth rib portion of between 50% and 70%, and the first to the fourth rib portion had between 20% and 40%. These intramuscular neural distribution-based injection sites are in relation to the external anatomical line for the frequently injected muscles to facilitate the efficiency of botulinum neurotoxin injections. Lastly, the intramuscular neural distribution of serratus anterior muscle should be considered in order to practice more accurately without the harmful side effects of trigger-point injections and botulinum neurotoxin injections.
引用
收藏
页数:9
相关论文
共 48 条
  • [21] Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Platysma Muscle for Treating Platysmal Band and Jawline Lifting: A Review
    Yi, Kyu-Ho
    Lee, Ji-Hyun
    Lee, Kangwoo
    Hu, Hye-Won
    Lee, Hyung-Jin
    Kim, Hee-Jin
    TOXINS, 2022, 14 (12)
  • [22] The botulinum neurotoxin for pain control after breast reconstruction: eural distribution of the pectoralis major muscle
    Yi, Kyu-Ho
    Lee, Ji-Hyun
    Kim, Hyoung-Moon
    Kim, Hee-Jin
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2022, 47 (05) : 322 - 326
  • [23] Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature
    Alka A. Bhide
    Federica Puccini
    Vik Khullar
    Suzy Elneil
    G. Alessandro Digesu
    International Urogynecology Journal, 2013, 24 : 1429 - 1434
  • [24] Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature
    Bhide, Alka A.
    Puccini, Federica
    Khullar, Vik
    Elneil, Suzy
    Digesu, G. Alessandro
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 (09) : 1429 - 1434
  • [25] A comparative study of lidocaine, botulinum toxin type a injection and dry needling in the treatment of myofascial pain syndrome
    Kamanli, A
    Kaya, A
    Ozgocmen, S
    Bayik, Y
    Ardicoglu, O
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 300 - 301
  • [26] Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials
    Leonardi, G.
    Alito, A.
    Portaro, S.
    Di Matteo, B.
    Respizzi, S.
    Kon, E.
    Massazza, G.
    Sconza, C.
    EUROPEAN JOURNAL OF PAIN, 2024, 28 (03) : 369 - 381
  • [27] Change in muscle hardness after trigger point injection and physiotherapy for myofascial pain syndrome
    Okada-Ogawa, Akiko
    Sekine, Naohiko
    Watanabe, Kosuke
    Kohashi, Ryutaro
    Asano, Sayaka
    Iwata, Koich
    Imamura, Yoshiki
    JOURNAL OF ORAL SCIENCE, 2019, 61 (01) : 36 - 44
  • [28] A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm
    Porta, M
    PAIN, 2000, 85 (1-2) : 101 - 105
  • [29] Dose- and Volume Dependent-Response to Intramuscular Injection of Botulinum Neurotoxin-A Optimizes Muscle Force Decrement in Mice
    Stone, Austin V.
    Ma, Jianjun
    Callahan, Michael F.
    Smith, Beth P.
    Garrett, Jeffrey P.
    Smith, Thomas L.
    Koman, L. Andrew
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2011, 29 (11) : 1764 - 1770
  • [30] Anterior knee pain caused by patellofemoral pain syndrome can be relieved by Botulinum toxin type A injection
    Chen, John Tzu-Ning
    Tang, Alice Chu-Wen
    Lin, Shih-Cherng
    Tang, Simon Fuk-Tan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2015, 129 : S27 - S29